Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments
Fierce Pharma
Thu, 11/10/22 - 10:37 am
Tags:
AstraZeneca
,
vaccines
,
COVID-19
Yes, no, maybe: FDA panel delivers mixed verdict on AstraZeneca's asthma rescue medication
Fierce Biotech
Wed, 11/9/22 - 10:43 am
Tags:
AstraZeneca
,
asthma
,
PT027
,
FDA
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
chronic kideny disease
,
Jardiance
,
Farxiga
,
AstraZeneca
AstraZeneca hands omnichannel ops mandate to Indegene
Medical Marketing and Media
Sun, 11/6/22 - 01:39 pm
Tags:
AstraZeneca
,
omnichannel
,
Indegene
Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators
Endpoints
Fri, 11/4/22 - 10:21 am
Tags:
Sanofi
,
AstraZeneca
,
RSV
,
nirsevimab
,
Europe
,
vaccines
AstraZeneca password lapse exposed patient data
TechCrunch
Thu, 11/3/22 - 07:27 pm
Tags:
AstraZeneca
,
patients
,
patient data
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Tags:
Kyowa Kirin
,
Takeda
,
Eiger BioPharmaceuticals
,
AstraZeneca
,
Teva Pharmaceutical
,
Bavarian Nordic
,
Halozyme
,
Novartis
,
MannKind
,
drug development
Daiichi Sankyo sets new highs for AstraZeneca-partnered cancer drug Enhertu
Endpoints
Mon, 10/31/22 - 04:15 pm
Tags:
Daiichi Sankyo
,
AstraZeneca
,
Enhertu
,
breast cancer
,
non-small cell lung cancer
AstraZeneca beats Roche twice in a day
EP Vantage
Wed, 10/26/22 - 10:20 am
Tags:
AstraZeneca
,
Roche
,
SERD
,
breast cancer
,
Ipatasertib
,
capivasertib
,
Camizestrant
Weak data for Fasenra undermine AZ’s ambitions for the drug
Pharmaphorum
Tue, 10/25/22 - 10:35 am
Tags:
AstraZeneca
,
Fasenra
,
eosinophilic asthma
,
chronic rhinosinusitis with nasal polyps
,
eosinophilic esophagitis
Novartis, eyeing $3B market, beats AstraZeneca blood disorder blockbusters in phase 3
Fierce Biotech
Mon, 10/24/22 - 11:17 pm
Tags:
Novartis
,
iptacopan
,
clinical trials
,
Soliris
,
AstraZeneca
,
Ultomiris
Charles River cuts the ribbon on former AstraZeneca site in the UK for plasmid manufacturing
Endpoints
Thu, 10/20/22 - 10:36 am
Tags:
Charles River Labs
,
UK
,
drug manufacturing
,
plasmid DNA
,
AstraZeneca
AstraZeneca hit with small fine in Korea over plot to stall generic of lucrative cancer med
Fierce Pharma
Fri, 10/14/22 - 10:21 am
Tags:
South Korea
,
Alvogen
,
AstraZeneca
,
Zoladex
AstraZeneca’s Covid-19 nasal-spray version fails in trial
Clinical Trials Arena
Tue, 10/11/22 - 10:45 am
Tags:
AstraZeneca
,
COVID-19
,
vaccines
,
clinical trials
,
intranasal vaccines
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks
,
AbbVie
,
Alnylam
,
AstraZeneca
,
Biogen
,
CRISPR Therapeutics
,
Daiichi Sankyo
,
Eisai
,
Eli Lilly
,
GSK
,
Intellia Therapeutics
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
Roche nets FDA approval for HER2-low breast cancer test paired with AstraZeneca-Daiichi's Enhertu
Fierce Biotech
Wed, 10/5/22 - 07:07 pm
Tags:
Roche
,
FDA
,
diagnostics
,
Medtech
,
HER2-low breast cancer
,
Enhertu
,
AstraZeneca
,
Daiichi Sankyo
AstraZeneca's Evusheld loses potency against new omicron subvariant, FDA warns
Fierce Pharma
Wed, 10/5/22 - 10:37 am
Tags:
AstraZeneca
,
COVID-19
,
Omicron BA.4.6
,
Evusheld
AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’
Endpoints
Wed, 10/5/22 - 10:35 am
Tags:
pharma marketing
,
DTC advertising
,
AstraZeneca
,
eosinophilic asthma
,
asthma
,
Fasenra
AstraZeneca pays 666% premium to buy genomic medicine biotech
Fierce Biotech
Mon, 10/3/22 - 10:26 am
Tags:
AstraZeneca
,
M&A
,
Alexion
,
LogicBio Therapeutics
,
genomic medicine
Go or no go? GSK takes its turn with a novel anemia class
EP Vantage
Fri, 09/30/22 - 10:52 am
Tags:
FDA
,
GSK
,
Amicus Therapeutics
,
AstraZeneca
,
Novartis
,
Supernus
,
JNJ
,
Ipsen
,
Y-mAbs Therapeutics
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.